Current Programmes

ICAPO currently brings its technical and policy expertise to bear in the following OECD activities:

  • Working Group of National Co-ordinators of the Test Guidelines Programme (WNT)
    • Expert Group on Ecotoxicity of Nanomaterials
    • Expert Group on Skin Sensitisation
    • Expert Group on skin and eye irritation and corrosion
    • Expert group on Non-Genotoxic Carcinogenicity
    • Working Group on Good Laboratory Practices
    • Expert Group on Dermal Absorption
    • Expert Group on Phototoxicity
    • Expert group on Miniaturised Ames test
    • EG on Intellectual Property issues in TGs 
    • Expert Group on Developmental Neurotoxicity
  • Task Force on Existing Chemicals
  • Working Party on Manufactured Nanomaterials  (WPMN)
    • Steering Group on Testing and Assessment of manufactured Nanomaterials
  • Working Party on Hazard Assessment  (WPHA)
    • Expert Group on the Development of the Global Chemicals Knowledge Base
    • Steering Group for the Development of the Global Portal to Information on Chemical Substances
    • Integrated Approaches to Testing and Assessment (IATA) Case Studies
    • QSAR Management Group
  • Endocrine Disrupters Testing and Assessment (EDTA)
    • Validation Management Group for Ecotoxicity Testing (VMG-ECO)
    • Validation Management Group for Non-Animal testing (VMG- NA)
    • Endocrine Disrupters Testing and Assessment Advisory Group (EDTA AG)
  • Extended Advisory Group on Molecular Screening and Toxicogenomics (EAGMST)
    • Expert Group for Developing a GD on Reporting of Metabolomics Data
  • Joint Meeting of the Chemicals Committee (JMCC)
  • Working Party on Chemicals, Pesticides, and Biotechnology (WPCPB)
  • Working Party on Exposure Assessment (WPEA)

ICAPO carries out its work at the OECD by participating in relevant OECD meetings and working groups, commenting on OECD draft test guidelines and other documents, and nominating outside experts to take part in OECD activities on ICAPO's behalf. ICAPO also works to ensure that member countries abide by their OECD treaty obligations under the Mutual Acceptance of Data provision, which obligates member countries to accept data from OECD-approved test guidelines instead of requiring duplicative animal testing.

Recently, ICAPO members formed a sister coalition-ICAPPP-to promote animal protection in pharmaceutical testing guidelines developed internationally through tripartite discussions among Japan, Europe, and the United States under the banner of the International Conference on Harmonisation (ICH) and other similar harmonization programmes.

ICAPO welcomes inquiries from outside experts interested in working on ICAPO's behalf on OECD-related activities. Please contact the ICAPO secretariat for more information.